- Stocks
- Pharma & Healthcare
- Source Natural
Source Natural share price
NSE: SOURCENTRLPharma & HealthcarePackaged Foods
Source Natural at a glance
With a market capitalisation of ₹70 Cr, it ranks 2877th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Packaged Foods.
Its return on equity was 14.2% in FY26. Promoters held 74.37% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹70 CrRank 2877 on NSE
- Price to book
- 2.71×FY26
- ROE
- 14.2%FY26
- ROCE
- 21.1%FY26
- Debt to equity
- 0.3FY26
- Net profit margin
- 5.2%FY26
- Book value / share
- ₹40.01FY26
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Source Natural financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹25 Cr | ₹22 Cr | ₹20 Cr | ₹27 Cr | ₹45 Cr | — |
| Operating profit | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | — |
| Net profit | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | — |
| EPS (₹) | ₹5.24 | ₹3.78 | ₹3.30 | ₹2.70 | ₹4.51 | — |
| Cash from operations | ₹4 Cr | ₹0 Cr | ₹3 Cr | ₹3 Cr | ₹0 Cr | — |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹13 Cr | ₹16 Cr | ₹18 Cr | ₹19 Cr | ₹22 Cr | ₹26 Cr |
Source Natural shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% | 74.37% |
| Non-institutions | 25.63% | 25.63% | 25.63% | 25.63% | 25.63% | 25.63% |
Source Natural vs peers
The listed Pharma & Healthcare companies nearest to Source Natural by market capitalisation.
Ask anything about Source Natural
Pivot answers on the live chart with evidence you can check, and tests strategies against SOURCENTRL's own history. Try: “Why has SOURCENTRL moved over the last three months?” · “Backtest a 50-day moving-average crossover on SOURCENTRL over five years” · “Compare SOURCENTRL with METSL on margins and valuation”
Frequently asked questions about Source Natural
What is the market cap of Source Natural?
Source Natural's market capitalisation is ₹70 Cr (₹70 Cr) at the 22 Oct 2026 close, ranking 2877th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Source Natural?
Return on equity was 14.2% in FY26 and return on capital employed was 21.1% in FY26 (standalone figures).
Is Source Natural a debt-free company?
No. Source Natural's debt-to-equity ratio was 0.3 in FY26, with total debt of ₹0 Cr.
What is the shareholding pattern of Source Natural?
As of 30 Jun 2026: promoters 74.37%, non-institutions 25.63%.
Who are Source Natural's competitors?
The listed Pharma & Healthcare companies closest to Source Natural by market cap are Maestros Elect, Bharat Immuno, Asston Pharma, Fervent Synergi, Sunil Health and Samrat Pharma.
Is Source Natural a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Source Natural's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SOURCENTRL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with S · all NSE stocks · this page as text